You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms by site

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

Rectal Cancer, Organ-Space Surgical Site Infection Trial in Granollers (Person-level linkage of both databases looking for

Completed
  • Rectal Cancer
  • Organ-Space Surgical Site Infection
  • Person-level linkage of both databases looking for concordance in the diagnosis of organ-space surgical site infection
  • Granollers, Barcelona, Spain
    Hospital General de Granollers
Oct 30, 2023

Oral Cancer, Oral Cavity Cancer, Donor Site Complication Trial (Split-Thickness Skin Graft for Radial Forearm Donor Site

Not yet recruiting
  • Oral Cancer
  • +2 more
  • Split-Thickness Skin Graft for Radial Forearm Donor Site Closure
  • Hatchet Flap for Radial Forearm Donor Site Closure
  • (no location specified)
Feb 21, 2023

Primary Ocular Adnexal MALT Lymphoma Trial (Rituximab, Involved Site Radiation Therapy)

Not yet recruiting
  • Primary Ocular Adnexal MALT Lymphoma
  • (no location specified)
Sep 26, 2023

Pancreas Tumor, Stomach Tumor, Gastrointestinal Tumors Trial (EO-3021)

Not yet recruiting
  • Pancreas Neoplasm
  • +5 more
  • (no location specified)
Jul 31, 2023

Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)

Recruiting
  • Breast Neoplasms
  • +7 more
  • Canton, Ohio
    Gabrail Cancer Center
Jan 24, 2023

Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
  • Routine care as per site standard.
  • (no location specified)
Sep 15, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)

Not yet recruiting
  • Lung Cancer
  • +8 more
  • Ion Endoluminal System
  • Orlando, Florida
  • +2 more
Aug 16, 2023

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
Has Results
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

Recruiting
  • Uterine Cervical Neoplasms
  • +10 more
  • Pembrolizumab/Vibostolimab Co-Formulation
  • +11 more
  • Anchorage, Alaska
  • +65 more
Jan 27, 2023

Cholelithiasis, Cholecystitis, Gallbladder Cancer Trial (single transversus abdominis laparoscopy-guided plane block, local

Not yet recruiting
  • Cholelithiasis
  • +2 more
  • single transversus abdominis laparoscopy-guided plane block
  • local trocar site ropivacaine infiltration
  • (no location specified)
Nov 13, 2023

Lung Cancer Trial

Not yet recruiting
  • Lung Cancer
    • (no location specified)
    Aug 17, 2023

    Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Jun 8, 2023

    Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

    Active, not recruiting
    • Breast Cancer
    • +7 more
    • Detroit, Michigan
    • +3 more
    Dec 22, 2022

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Papillary Thyroid Carcinoma Trial in Guangzhou (Retro-Auricular Single-Site Endoscopic Thyroidectomy, Transoral Endoscopic

    Recruiting
    • Papillary Thyroid Carcinoma
    • Retro-Auricular Single-Site Endoscopic Thyroidectomy
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Mar 6, 2023

    Urothelial Bladder Cancer, Triple-negative Breast Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Tremelimumab

    Active, not recruiting
    Has Results
    • Urothelial Bladder Cancer
    • +2 more
    • Tremelimumab monotherapy
    • +2 more
    • San Francisco, California
    • +13 more
    Jan 20, 2023

    Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

    Terminated
    • Neoplasms
    • New Haven, Connecticut
    • +20 more
    Sep 15, 2023

    Solid Tumors Trial in Japan (E7389-LF, Nivolumab)

    Active, not recruiting
    • Solid Neoplasms
    • Nagoya, Aichi, Japan
    • +18 more
    Jan 31, 2023

    Bone Cancer, Bone Tumor, Solid Tumor Trial in United States (153-Sm-DOTMP (Samarium-153-DOTMP))

    Recruiting
    • Bone Cancer
    • +4 more
    • 153-Sm-DOTMP (Samarium-153-DOTMP)
    • Chicago, Illinois
    • +3 more
    Aug 18, 2023

    (ROSE) for Head and Neck Fine Needle Aspirations (FNA)

    Completed
    • Head and Neck Neoplasms
    • Olympus Cellsens software
    • Truro, Cornwall, United Kingdom
      Royal Cornwall Hospital
    Jul 27, 2023

    Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Tumors Trial in Worldwide (AZD9592, Osimertinib)

    Recruiting
    • Advanced Solid Tumours
    • +2 more
    • Duarte, California
    • +13 more
    Jan 5, 2023

    es in OVArian Cancer HRD+ Status in Russian Federation

    Recruiting
    • Ovarian Cancer
      • Arkhangelsk, Russian Federation
      • +18 more
      Jun 26, 2023

      Lenvatinib in Combination With Pembrolizumab in Korean Patients

      Recruiting
      • Endometrial Neoplasms
      • +2 more
      • Non-interventional
      • Ilsan, Gyeongji-do, Korea, Republic of
      • +14 more
      Nov 21, 2022